NASDAQ NMS - GLOBAL MARKET · GDTC
-7.24% · -$0.0746 · Vol 74.0K
Market closed · last close 4:00 PM ET · price as of 18:34:28 ET
CytoMed Therapeutics Ltd

CytoMed Therapeutics Ltd

Biotechnology
$0.9554
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Sentiment absence reason unknown
GDTC
CytoMed Therapeutics Ltd
Mon Aug 24 · last completed session · Markets closed · resumes Tue 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

45/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Mon Aug 24 · last completed session · Markets closed · resumes Tue 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is GDTC moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading GDTC catalysts
About CytoMed Therapeutics Ltd
Biotechnology
Listed since
2023
Employees
42
Country
SG

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.00
Day high
$1.00
Day low
$0.9275
Previous close
$1.03
52W high
$2.69
-64.48% from high
52W low
$0.7232
12% of range
Market cap
$12.2M
EPS
$-0.3421
Beta
-0.13
Shares out
11.8M
Volume
74K
0.50× rel vol
Avg volume
148.8K
VWAP
$0.9676
Price history computed in-house
1W
+1.68%
1M
-3.49%
3M
-20.38%
1Y
-51.56%
YTD
-28.43%
SMA 50 $0.9629 · below
SMA 200 $1.17 · below
52W position 12%

GDTC overview

Veridion Score
45
Registered · 2026-08-24
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around GDTC.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading GDTC Form 4 filings
Public disclosures

Congress activity in GDTC

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for GDTC in the cached public ledger.

Federal contracts

GDTC contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for GDTC in this window.
Lobbying spend

GDTC lobbying filings, year to date.

Registered lobbying filings matched to CytoMed Therapeutics Ltd.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for GDTC in this window.
Loading news for GDTC
Analyst ratings
Sovereign unlock shows live analyst consensus for GDTC.
Options
Sovereign unlock shows live options positioning for GDTC.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.